European researchers developing organoids to spare Type 1 diabetics from lifelong insulin therapy

European researchers developing organoids to spare Type 1 diabetics from lifelong insulin therapy

by Vittorio Hernandez in International Business Times
on April 04 2016European researchers developing organoids to spare Type 1 diabetics from lifelong insulin therapy

The Australian edition of the International Business Times has dedicated an article to LSFM4LIFE project on April 4, 2016, giving accurate details about the process to develop pancreatic
organoids and introducing the project’s ultimate ambition to transplant three-dimensional cellular structures of insulin-producing cells into diabetes patients’ pancreas.

 

Related link

Read the entire article here: www.ibtimes.com.au

Leave a Reply

Your email address will not be published. Required fields are marked *